WST - West Pharmaceutical Services, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
337,400
235,900
203,000
274,600
Short Term Investments
-
-
-
-
Total Cash
337,400
235,900
203,000
274,600
Net Receivables
288,200
253,200
200,500
181,400
Inventory
214,500
215,200
199,300
181,100
Other Current Assets
54,300
39,200
39,100
36,600
Total Current Assets
894,400
743,500
641,900
673,700
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,752,700
1,745,800
1,554,700
1,440,300
Accumulated Depreciation
-930,700
-890,800
-776,400
-719,300
Net property, plant and equipment
822,000
855,000
778,300
721,000
Equity and other investments
91,200
85,800
82,700
61,300
Goodwill
105,800
107,700
103,000
104,600
Intangible Assets
20,400
21,700
23,300
37,600
Other long-term assets
20,500
23,400
21,300
26,400
Total non-current assets
1,084,600
1,119,300
1,074,800
1,021,400
Total Assets
1,978,900
1,862,800
1,716,700
1,695,100
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
100
0
2,400
69,300
Accounts Payable
130,400
138,100
122,000
119,800
Taxes payable
9,800
6,000
4,500
12,800
Accrued liabilities
90,700
83,900
71,900
76,100
Deferred revenues
25,500
18,400
13,200
14,400
Other Current Liabilities
13,600
20,500
15,300
7,700
Total Current Liabilities
283,700
279,500
241,000
314,300
Non-current liabilities
Long Term Debt
196,000
197,000
226,200
228,900
Deferred taxes liabilities
13,100
10,400
9,200
12,400
Deferred revenues
-
-
-
-
Other long-term liabilities
33,600
42,600
47,200
53,600
Total non-current liabilities
298,900
303,400
358,200
356,900
Total Liabilities
196,100
197,000
228,600
298,200
Stockholders' Equity
Common Stock
18,800
18,800
18,400
18,100
Retained Earnings
1,353,400
1,178,200
1,071,600
964,600
Accumulated other comprehensive income
-154,200
-117,300
-186,800
-162,600
Total stockholders' equity
1,396,300
1,279,900
1,117,500
1,023,900
Total liabilities and stockholders' equity
1,978,900
1,862,800
1,716,700
1,695,100